How The Autolus Therapeutics (AUTL) Narrative Is Shifting With Recalibrated Targets And Fair Value [Yahoo! Finance]
Autolus Therapeutics plc - American Depositary Shares (AUTL)
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am
Check Earnings Report
US:NASDAQ Investor Relations:
autolus.com/investor-relations
Company Research
Source: Yahoo! Finance
Autolus Therapeutics has seen its modeled fair value move from US$8.79 to US$8.81, a very modest adjustment that still matters for anyone tracking the stock's valuation story. Recent Street research links this shift to refreshed price target work, as analysts reassess discount rates, revenue trajectories, and risk around execution before resetting where they see upside and downside for the shares. As you read on, you will see how this evolving narrative can help you stay aligned with what changing targets may signal for your own research process. Stay updated as the Fair Value for Autolus Therapeutics shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Autolus Therapeutics. What Wall Street Has Been Saying ?? Bullish Takeaways Mizuho and H.C. Wainwright are both still engaged on Autolus Therapeutics, which suggests the story remains active on research desks even as they update their models and targets. Fo
Show less
Read more
Impact Snapshot
Event Time:
AUTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUTL alerts
High impacting Autolus Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AUTL
News
- Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical developmentGlobeNewswire
- Autolus Therapeutics (AUTL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.MarketBeat
- Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights Transcript [Seeking Alpha]Seeking Alpha
- Autolus Therapeutics Highlights obe-cel Momentum in ALL With New Real-World ROKA and Pediatric Data [Yahoo! Finance]Yahoo! Finance
- Autolus Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
AUTL
Earnings
- 3/27/26 - Miss
AUTL
Sec Filings
- 4/16/26 - Form 8-K
- 4/15/26 - Form DEL
- 4/15/26 - Form DEL
- AUTL's page on the SEC website